Clinical Trials Logo

Clinical Trial Summary

A phase Ia study to evaluate the safety, tolerance, pharmacokinetics and preliminary efficacy of IBI345 in patients with CLDN18.2 positive solid tumors


Clinical Trial Description

n/a


Study Design


NCT number NCT05199519
Study type Interventional
Source Innovent Biologics (Suzhou) Co. Ltd.
Contact
Status Completed
Phase Phase 1
Start date December 13, 2021
Completion date January 19, 2023